Regeneron to boost its US manufacturing through a $3B Fujifilm deal

Anna Brown

News Reporter

Fujifilm Diosynth Biotechnologies’ bet on its North Carolina biologics facility is paying off, as Regeneron plans to shell out several billion dollars to move manufacturing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Regeneron to boost its US manufacturing through a $3B Fujifilm deal

Anna Brown

News Reporter

Sign up to read this article for free.

Vice President, Biology & Translational Research

Gondolabio

Palo Alto, CA, USA

Vaccine biotechs say they’ve been told to stop next-gen Covid work under a Biden-era project

Recent FDA staff cuts to delay drug hearing decision by months, agency tells Vanda

Drugmakers stockpile inventory in the US, seeking to get ahead of Trump tariffs

Updated: Roche’s $50B US investment includes previous build announcements

Galapagos CEO Paul Stoffels to step down, former Neumora chief to lead spinout

ADSTILADRIN® (nadofaragene firadenovec-vncg) – A Growing Body of Clinical Data and Real-World Evidence

Re­gen­eron to boost its US man­u­fac­tur­ing through a $3B Fu­ji­film deal

News Reporter

Sign up to read this article for free.

Gondolabio

Palo Alto, CA, USA

Regeneron to boost its US manufacturing through a $3B Fujifilm deal